Gotham Asset Management, LLC - ENANTA PHARMACEUTICALS INC ownership

ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 144 filers reported holding ENANTA PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is 1.12 and the average weighting 0.2%.

Quarter-by-quarter ownership
Gotham Asset Management, LLC ownership history of ENANTA PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2020$720,000
-60.5%
13,990
-52.5%
0.02%
-39.4%
Q4 2019$1,821,000
-25.3%
29,479
-27.3%
0.03%
-23.3%
Q3 2019$2,437,000
-10.7%
40,570
+25.4%
0.04%
-2.3%
Q2 2019$2,729,000
+53.1%
32,345
+73.4%
0.04%
+69.2%
Q1 2019$1,782,000
+11.9%
18,652
-17.0%
0.03%
+4.0%
Q4 2018$1,592,000
-38.4%
22,482
-25.6%
0.02%
-30.6%
Q3 2018$2,584,000
+47.0%
30,234
+99.3%
0.04%
+44.0%
Q2 2018$1,758,000
+42.5%
15,172
-0.5%
0.02%
+47.1%
Q1 2018$1,234,000
+86.4%
15,249
+35.2%
0.02%
+70.0%
Q4 2017$662,000
+16.8%
11,276
-6.9%
0.01%
+25.0%
Q3 2017$567,000
-18.2%
12,112
-37.1%
0.01%
-20.0%
Q2 2017$693,000
-41.7%
19,268
-50.1%
0.01%
-33.3%
Q1 2017$1,188,000
-30.0%
38,581
-23.8%
0.02%
-31.8%
Q4 2016$1,696,000
-7.0%
50,629
-26.1%
0.02%
-8.3%
Q3 2016$1,823,000
-25.7%
68,514
-38.4%
0.02%
-17.2%
Q2 2016$2,453,000
-5.8%
111,236
+25.5%
0.03%0.0%
Q1 2016$2,603,000
-76.9%
88,631
-71.6%
0.03%
-73.6%
Q3 2015$11,270,000
+118.7%
311,850
+172.3%
0.11%
+155.8%
Q2 2015$5,153,000
+251.5%
114,532
+139.3%
0.04%
+290.9%
Q1 2015$1,466,000
+153.6%
47,871
+321.1%
0.01%
+120.0%
Q4 2014$578,000
-72.0%
11,367
-78.2%
0.01%
-76.2%
Q3 2014$2,067,00052,2300.02%
Other shareholders
ENANTA PHARMACEUTICALS INC shareholders Q3 2015
NameSharesValueWeighting ↓
Krensavage Asset Management, LLC 511,186$43,686,00011.23%
GREAT POINT PARTNERS LLC 210,400$17,981,0002.80%
ARMISTICE CAPITAL, LLC 456,000$38,970,0002.34%
Matarin Capital Management, LLC 210,208$17,964,376,0001.16%
Sapphire Star Partners LP 8,168$698,0000.70%
Granahan Investment Management 103,320$8,830,0000.48%
FARALLON CAPITAL MANAGEMENT LLC 867,500$74,137,0000.44%
361 CAPITAL LLC 19,040$1,627,0000.35%
ALGERT GLOBAL LLC 17,922$1,532,0000.33%
AlphaMark Advisors, LLC 9,310$796,0000.32%
View complete list of ENANTA PHARMACEUTICALS INC shareholders